Cite
HARVARD Citation
Lavingia, V. et al. (2022). Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2–overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study. SAGE open medical case reports. p. . [Online].